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  Angelman syndrome is characterized by a partial deficit of paired autosomal chromosome 15, which contains a 
subunit of the GABA (Gamma-Amino Butyric Acid) receptor. Many drugs that act on the CNS (Central Nerve System) 
during anesthesia are believed to exert their effects via the GABA receptors. We describe the anesthesia of a 7 year-old 
female patient with Angelman syndrome who underwent surgery for dental caries. The basic factors that needed to 
be considered when administering anesthesia to this patient were epilepsy, significant dominance of the vagal tone, 
craniofacial abnormalities and peripheral muscular atrophy. Inhalational anesthetics (sevoflurane) were employed 
for this patient. The patient had an uneventful peri-operative period and was discharged home on the same day of 
the operation.  (Korean J Anesthesiol 2010; 58: 207-210)
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    Angelman syndrome was first reported by Harry Angelman 
in 1965 [1]. This syndrome is characterized by bouts of laughter, 
intellectual retardation, cerebella ataxia, severe developmental 
delay, malformations of the skull and facial bones, seizures, etc. 
Such characteristics are due to a partial deficit on a region of 
paired chromosome 15. The chromosome defect is responsible 
for the dysfunction of the GABA (Gamma-Amino Butyric Acid) 
receptor, as well as the damage to the synthesis and secretion 
of GABA [2-4]. The GABA receptor is a common channel for the 
action of many drugs used for general anesthesia. Patients with 
Angelman syndrome have an impairment of this receptor, and 
need to be placed under general anesthesia even for a simple 
procedure. The anesthetic problems related to the syndrome 
involve seizures, hyperfunction of vagus nerves, malformations 
of the skull and facial bones, peripheral muscular atrophy, etc. 
We report a case of general anesthesia of a 7 year-old female 
outpatient with Angelman syndrome for the treatment of dental 
caries with a review of the relevant literature. This case shows 
that peripheral muscular atrophy in general anesthesia for 
outpatients requires more careful attention.
Case Report
    A 7 year-old, 113 cm, 17 kg, female patient with tooth decay 
presented for general anesthesia for tooth conservation day 
surgery because outpatient treatment was not possible due 208 www.ekja.org
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to her lack of cooperation. Her medical history showed that 
she had been delivered normally after 39 weeks of gestation, 
weighing 2.8 kg. At birth, the child had a weak suck. Seven 
months after birth, pediatric parent visits were made due to a 
general developmental delay, microcephaly, and sleep disorder. 
Fourteen months after birth, brain MRI (Magnetic Resonance 
Imaging) was performed, which revealed no abnormalities. 
However, a chromosomal study showed a deficiency of 
Chromosome 15 at q11.2−q13, and a FISH (Fluorescence in 
situ hybridization) test confirmed Angelman syndrome (Fig. 1). 
From 23 months after birth, spasms began to occur, which 
became severe when the sleep disorder happened frequently. 
At approximately age 4, general myoclonus epilepsy occurred. 
Thereafter, she took valproic acid 125 mg, in divided into two 
doses two times per day, and experienced convulsion at 3 
to 5 months intervals. An SMS (Social Maturity Scale) test, 
which was taken in the 30 month after birth, revealed severe 
intellectual retardation with a social age of 0.32. Regarding 
motor development, she was equivalent to a 4−7 month old 
for the Gross motor, 1−4 month old for the Fine motor, and 1−2 
months old for language development.
    The neurological test revealed that the child's flexor in the 
arms and legs was hyper-tensed, her skeletal muscle was 
not fully developed, and she showed slight dystonic tremor. 
The morphological characteristics were microcephaly and 
hypoplasia of the maxillary bones. In the anteroom for 
day surgery, the child patient was uncooperative with the 
medical staff and would not leave her parent. The girl could 
not walk, and she was nestling in her parent's arms, speaking 
incomprehensible words and making infelicitous laughs. The 
blood test before the operation revealed a hemoglobin level 
of 11.8 g/dl, which was slightly low. However, there were no 
abnormalities found in the electrocardiogram and chest X-ray. 
    In the anteroom for day surgery, an intravenous route was 
secured with the assistance of the surgical staff and parent. 
For the induction of general anesthesia, midazolam 2 mg 
instead of the ketamine commonly used in the hospital was 
administered with concern over seizure. However, it failed to 
sedate her and another 2 mg was administrated, which had 
no effects. A decision was made not to use different kinds of 
intravenous anesthetics because of the concern about the delay 
in awakening and restoration from anesthesia. The girl was 
carried into the operating room (OR) in her parent’s arms. The 
vital signs immediately after entering the OR revealed a blood 
pressure, pulse rate and oxygen saturation of 110/60 mmHg, at 
110/min and 96%, respectively. Sevoflurane and 100% oxygen 
were employed to induce anesthesia, and after administering 
rocuronium bromide 10 mg as a muscle relaxant, mask 
ventilation began and there was no difficulty in ventilation. 
After confirming full muscle relaxation, an orotracheal 
intubation was performed with a cuffed endotracheal tube 
(4.5 mm) without problems. Expecting trouble in endotracheal 
intubation, oropharyngeal intubation was first performed 
and the operation proceeded while maintaining orotracheal 
intubation at the consent of the pediatric dentistry department. 
 By regulating the oxygen to air ratio to set a Fraction of Inspired 
Oxygen (FiO2) at 0.5, controlled respiration was performed 
to maintain a partial carbon dioxide pressure in expiration of 
30−35 mmHg while maintaining anesthesia with sevoflurane 
3 vol%. During surgery, the blood pressure and pulse oximetry 
was stable at 100−110/60−70 mmHg and 99-100%, respectively. 
After surgery, spontaneous respiration was fully restored by 
manual ventilation. Pyridostigmine 5 mg and glycopyrrolate 
0.15 mg were then administrated to reverse muscle relaxant. 
Before extubation, the Train of Four (TOF) stimuli was 
measured to indicate 3 and the endotracheal tube was removed 
after confirming that the muscle function had been fully 
restored. The total length of time for tooth conservation surgery 
was 100 minutes, and the length of anesthesia was 125 minutes. 
In the postanesthetic recovery unit, the patient showed stable 
breathing and vital signs and her motion functions were 
checked after reaching consciousness. She was discharged 
home without complications. The next day's follow-up phone 
call also confirmed her good general condition without 
significant complications. 
Discussion 
     Angelman Syndrome (AS) is a congenital disorder showing 
a variety of clinic manifestations due to a partial deficit on 
the paired chromosome 15. The prevalence of AS is one in 
10,000−40,000 of the population and its clinical characteristics 
Fig. 1. FISH test of the patient. Arrowhead: normal chromosome 15; 
the red signal (SNRPN, small nuclear ribonucleoprotein polypeptide 
N) below green signal (centromere [D15Z1] region), Arrow: del (15) 
(q11.2q13); no red signal (SNRPN, small nuclear ribonucleoprotein 
polypeptide N).209 www.ekja.org
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are so diverse that a diagnosis of AS rests on a combination of 
molecular genetic testing and/or cytogenetic analysis. 70% of 
AS patients have the loss of the maternally contributed region 
of Chromosome 15q11-13, while 15% of AS have uniparental 
disomy coming from a paternal contribution. 60% of the paternal 
deletion in the chromosome region 15q11-13 may cause 
Prader-Willi Syndrome (PWS) [4]. The characteristic symptoms 
of PWS can be differentiated from those of AS by the clinical 
features, by hypotonicity and early obesity in infancy, mental 
retardation and hypogonadsm. Genetic imprinting refers to the 
accentuation or activation of genes that can be expressed in a 
parent-of-origin-specific manner. For the remaining 20% of AS 
cases, no genetic malformation is manifested but patients have 
a mutation of the UBE3A gene and show fewer abnormalities 
in the electroencephalographic (EEG) findings and a smaller 
number of spasms [5]. 
    The clinic features of a genetic mutation and deficiency vary 
according to the gene expressions of RB3, which is critical in 
the genetic coding of the β 3 subunit of the GABA-Areceptor [6]. 
Many drugs acting on the central nervous system, such as anti-
anxiety medication, sedative-hypnotics, general anesthetics, 
anti-seizure drugs, etc. are considered to acton the GABA 
receptor. A study on genetically manipulated mice of aminoacid 
mutated from the β 3 subunit of the GABA receptor showed that 
reduced effects of propofol and etomidate [7]. Homanics et al. [8] 
reported a meaningful decrease in benzodiazepine binding in 
genetically manipulated mouse models of Angelman syndrome. 
In the present case, midazolam 4 mg was administered into 
the vein before surgery to reduce the patient's anxiety, but she 
was not sedated. Similarly, reciprocal interactions between the 
receptor region and intravenous anesthetics warrant further 
study. Sugimura et al. [9] and Gyulai et al. [10] revealed the 
influence of halogenated ether on the GABA receptors. A 
change in the distribution of the receptors caused by isoflurane 
and partly by sevoflurane activates the outer structure of the 
synapse through osmotic changes in ions. Such a polar change 
in neuronal cells not only restrains the activity of neuronal cells 
themselves but also reflect the state of the general anesthetics.
    Therefore, it is reasonable to minimize or avoid administering 
an excessive dose of benzodiazepine to patients with this 
syndrome, and to refrain from using halogenated ethers as an 
inhalation anesthetic. From a theoretical viewpoint, intravenous 
anesthesia using a combination of propofol and fentanyl, which 
are not known to collide with the GABA system, will be safe [11]. 
    On the other hand, patients with AS can show symptoms 
of separation anxiety due to their severe mental retardation. 
For child patients who show separation anxiety at general 
anesthesia for outpatient surgery, securing an intravenous 
route after admitting the patients into the operating room 
accompanied by their parents and sedating them with 
inhalation anesthetics is desirable for reducing the children's 
anxiety.
    Patients with this syndrome usually require general anesthesia 
for orthopedic surgery for the skeletal system dysfunction or 
even in a simple operation because they are uncooperative 
[12]. AS may not be detected at birth or during infancy, and is 
revealed mainly after the age of four, when the characteristic 
behaviors and signs appear. With several exceptions, the life 
expectancy generally does not exceed 15 years [3,4]. Table 1 
Table 1. Developmental and Physical Findings in Angelman Syn-
drome [13]
Consistent (100%)
• Developmental delay, functionally severe
• Movement or balance disorder, usually ataxia of gait and/or trem-
ulous movement of limbs. Movement disorder can be mild. May 
not appear as frank ataxia but can be forward lurching, unsteadi-
ness, clumsiness, or quick, jerky motions
• Behavioral uniqueness: any combination of frequent laughter/
smiling; apparent happy demeanor; easily excitable personality, 
often with uplifted hand-flapping or waving movements; hyper-
motoric behavior
• Speech impairment, none or minimal use of words; receptive and 
non-verbal communication skills higher than verbal ones 
Frequent (more than 80%)
• Delayed, disproportionate growth in head circumference, usually 
resulting in microcephaly (≤2 S.D. of normal OFC) by age 2 years. 
Microcephaly is more pronounced in those with 15q11.2-q13 de-
letions.
• Seizures, onset usually <3 yrs. of age. Seizure severity usually de-
creases with age but the seizure disorder lasts throughout adult-
hood.
• Abnormal EEG, with a characteristic pattern, as mentioned in the 
text. The EEG abnormalities can occur in the first 2 years of life 
and can precede clinical features, and are often not correlated to 
clinical seizure events. 
Associated (20−80%)
• Flat occiput
• Occipital groove 
• Protruding tongue
• Tongue thrusting; suck/swallowing disorders
• Feeding problems and/or truncal hypotonia during infancy
• Prognathia
• Wide mouth, wide-spaced teeth
• Frequent drooling
• Excessive chewing/mouthing behaviors
• Strabismus
• Hypopigmented skin, light hair and eye color (compared to family), 
seen only in deletion cases
• Hyperactive lower extremity deep tendon reflexes
• Uplifted, flexed arm position especially during ambulation
• Wide-based gait with pronated or valgus-positioned ankles
• Increased sensitivity to heat
• Abnormal sleep wake cycles and diminished need for sleep
• Attraction to/fascination with water; fascination with crinkly items 
such as certain papers and plastics
• Abnormal food related behaviors
• Obesity (in the older child)
• Scoliosis
• Constipation210 www.ekja.org
Anesthesia of a dental patient with Angelman syndrome Vol. 58, No. 2, February 2010
shows the consensus criteria of the clinical features in AS, 
enacted in 2005 [13].
    Patients with AS do not have cardiovascular disorders or 
arrhythmia as common features but may have bradycardia 
due to hypertension of the vagus nerves. This phenomenon 
is noticed mainly during convulsive laughter, which can 
contribute to severe arrhythmia or ventricular asystole or 
fainting, resulted from an increase in the intrathoracic pressure 
and Valsalva effect. The administration of atropine to treat 
the unexpected arrhythmia during surgery is not always 
effective. Moreover, the immediate use of cardiac massage and 
epinephrine should be considered if asystole occurs [14]. 
    Malformations of the skull and facial bones (microcephaly, 
mandibular bulging, etc.) found in patients with AS can be a 
serious hindrance to tracheal intubation. However, the present 
case did not experience significant difficulty, and the literature 
review has not reported any difficulty in tracheal intubation. 
However, preparations should be made for any possible 
contingency when an unexpected malformation is confronted.
    Many patients with AS take medication for hyperactivity 
and epilepsy. To prevent perioperative epilepsy, it will be 
wise to keep taking anti-seizure drugs during the operation. 
However, it is unclear if all patients with AS should take anti-
seizure medication as preventive medicine. When choosing 
anesthetics, drugs that can cause seizure, such as ketamine or 
enflurane, should be avoided.
    Peripheral muscular atrophy is another problem that needs 
to be considered when administrating anesthesia to patients 
with AS. When it does occur, the sensitivity may increase, and 
a smaller amount of muscle relaxant than the usual dosage 
should be applied. Monitoring the level of muscle relaxation is 
required to ensure the appropriateness in the degree of muscle 
relaxation during operation and during restoration from muscle 
relaxation after surgery. In the present case, the anesthesia 
was induced with inhalation anesthetics and maintained 
with a small dose of muscle relaxant, while there were no 
added muscle relaxants except those administered before the 
induction of anesthesia. TOF (Train of Four) stimuli indicated 
a count of 3 before extubation after surgery. The endotracheal 
tube was removed safely and spontaneous respiration resumed. 
 In conclusion, monitoring of the muscle relaxation of patients 
is necessary because of the possible risks of seizures and 
peripheral muscular atrophy. In particular, for outpatient 
surgery, extra precautions against accidents, such as falls 
due to muscular atrophy, should be taken after being 
discharged home. In addition, preparations should be made 
for emergencies, such as arrhythmia and ventricular asystole 
due to the hypertension of the vagus nerves. The difficulty in 
securing the respiratory tract in cases with malformations of the 
facial bones should be anticipated. In addition, proper attention 
should be paid to the choice of intravenous anesthetics and 
their correct dose in an abnormal case of an impairment of the 
GABA receptors. 
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